A Study in Adult and Pediatric Patients With Cystic Fibrosis
NCT00034515
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
denufosol tetrasodium (INS37217) Inhalation Solution
Sponsor
Merck Sharp & Dohme LLC